Xanthine oxidase inhibitors in ischaemic heart disease

Mihnea Zdrenghea1, Adela Sitar-Tăut2, Gabriel Cismaru2

  • 1Department of Haematology, Iuliu HaŢieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Insights

Allopurinol, a xanthine oxidase inhibitor, reduces ischaemic heart disease risk by improving endothelial function and reducing oxidative stress. Its benefits in stable angina are recognized, but more research is needed for acute myocardial infarction patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Elevated uric acid levels are linked to cardiovascular disease, especially ischaemic heart disease.
  • Xanthine oxidase inhibitors, like allopurinol, mitigate ischaemic heart disease risk via antioxidant and endothelial effects.

Purpose of the Study:

  • To evaluate the role of allopurinol in managing ischaemic heart disease.
  • To assess allopurinol's impact on exercise tolerance and cardiac remodeling.

Main Methods:

  • Review of existing studies on allopurinol in ischaemic heart disease patients.
  • Analysis of allopurinol's effects on exercise parameters and left ventricular hypertrophy.

Main Results:

  • Allopurinol improves exercise tolerance in stable angina by delaying ST depression and chest pain.
  • Evidence suggests allopurinol may benefit patients undergoing angioplasty, but data for acute myocardial infarction is limited.
  • Allopurinol demonstrates potential in regressing left ventricular hypertrophy and enhancing cardiac rehabilitation outcomes.

Conclusions:

  • Allopurinol's efficacy in stable angina is supported by recent guidelines.
  • Further investigation is required to establish the definitive role of allopurinol in acute myocardial infarction and its broader application in ischaemic heart disease management.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.8K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.7K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.1K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K